Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Intesa Sanpaolo SpA (ISP)

Milan
Currency in EUR
Disclaimer
3.5030
-0.0140(-0.40%)
Closed

ISP Comments

Già 20cent, di escursione...poveracci quelli che hanno ceduto in stop loss
Will there be a deeper corection, or does it have one more higher wave?
come vola oggi maury fdp
E'un titolo da acquistare senza se e senza ma, perche'dara'i suoi frutti.
Any target price for 2021?
2.50ish I guess
already gone 2021
Rosso...
Vediamo come apre
flyyyy NL0012666390
Nell'attesa che il titolo di Intesa migliori, aspettiamo almeno un dividendo piu'sostanzioso quest'anno previo ok della bce.
So, Where is the bottom? 1.3836 or deeper?
Domani 1.45
non scenderà ancora ormai e gia bassa considerando 0.19 div non distribuito quotazione ridicola rende solo div 13% ultimi report utili erano in rialzo quindi i prossimi anche se in contrazione saranno buoni in rapporto al prezzo
Si va direzione 1,458 entro due-tre settimane li poi si ricompra sperando nel ok dividendo della BCE
Penso che le azioni di Intesa saliranno ancora di molto perche'e'una banca solida, di fiducia e dara'i suoi frutti agli investitori che scelgono le proprie azioni.
do you think from Monday will rise up ?
Dears, che commentate in italiano.. siete sulla versione sbagliata ^_^ mey be better if you switch to the italian version ;)
mey ahahah mamma mia ^_^
Who da funk are you?
buongiorno potete darmi un applicazione per vedere le azioni in tempo reale....,questa inizia a perdere colpi
where do you think can go?
2 easy in 3/4 months maxWithout 2 wave
3
 To secure the Italian government's backing, Euronext has teamed up with state agency Cassa Depositi e Prestiti (CDP) and Italy's biggest bank Intesa SanPaolo (MI:ISP), who will subscribe to 700 million euros of Euronext's equity issue.
Oggi parla Lagarde... Magari scende...
Presto a 1.8...e speriamo nei dividendi!!
dove andiamo?
SALE FINO A 1,75 E SI STABILIZZA DOMANI A 1,72
https://www.thefinancewits.com/
Da Trump iniziazione di fiducia per Diasorin? President Donald Trump’s administration announced Friday it is awarding $1.3 million to two companies trying to develop rapid COVID-19 tests that could detect whether a person is positive for the new coronavirus within an hour. The Department of Health and Human Services said it is awarding $679,000 to DiaSorin Molecular, of Cypress, California, and $598,000 to QIAGEN, of Germantown, Maryland, to accelerate the development of their tests.
target 3,50€
Target 1.80, altro che 3.50...cambiate lavoro!
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.